As INPP4B promotes ER+ breast cancer cell proliferation and tumor growth via enhanced Wnt/β-catenin signaling [24], we predict that pyrvinium reduces cell viability via Wnt/β-catenin suppression. Here, ESR1 is linked to breast cancer.